CRP improves cardiovascular risk prediction in metabolic syndrome. (Proteomics).Blood levels of C-reactive protein (CRP C-reactive protein (CRP) A protein present in blood serum in various abnormal states, like inflammation. Mentioned in: Pelvic Inflammatory Disease CRP, n.pr See C-reactive protein. ) can help predict cardiovascular risk in women with metabolic syndrome, according to Harvard research reported recently in Circulation: Journal of the American Heart Association American Heart Association (AHA), n.pr a national voluntary health agency that has the goal of increasing public and medical awareness of cardiovascular diseases and stroke, and thereby reducing the number of associated deaths and disabilities. . High levels of CRP, a marker of inflammation, have been associated with increased risk of heart attack, stroke and type 2 diabetes type 2 diabetes n. See diabetes mellitus. . Metabolic syndrome, associated with a significant increase in cardiovascular risk, is the clustering of three or more of five conditions: abdominal obesity, high triglycerides Triglycerides Fatty compounds synthesized from carbohydrates during the process of digestion and stored in the body's adipose (fat) tissues. High levels of triglycerides in the blood are associated with insulin resistance. , low levels of HDL cholesterol, high blood pressure and high glucose levels. Harvard researchers studied data from 14,719 participants in the ongoing Women's Health Study, and reported that their analysis of women with metabolic syndrome showed that those with the highest CRP levels (greater than 3.0 mg/L) were 2.1 times more likely to have a cardiovascular event than those with the lowest CRP levels (less than 1.0 mg/L). |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion